Patent · US Expired

TCF-1 nucleotide sequence variation

US6656691B2 · kind B2 · utility

1Cited by

0References

11Claims

0Family size

Assignee

Roche Molecular Systems, Inc. · US

Inventors

Ann Begovich · Corona, US
Henry A. Erlich · Oakland, US
Andrew Grupe · Belmont, US
Janelle A. Noble · Berkeley, US
Gary Peltz · Redwood City, US
Rebecca Lynne Reynolds · Alameda, US
Karen Walker · Alameda, US
Gabriele Zangenberg · Tutzing, DE

Key dates

Filing date	Jul 12, 2001
Grant date	Dec 2, 2003
Priority date	—
Expiry date	Jul 12, 2021

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12Q2600/156
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

Methods and reagents for determining sequence variants present at the TCF-1 locus, which facilitates identifying individuals at risk for Th1 diseases, such as type 1 diabetes or multiple sclerosis, or Th2 diseases, such as allergic asthma or atopy.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.